George C. Prendergast
Nature Medicine · 2005
A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 2 researchers here, as inferred from the citation graph.
Whom George C. Prendergast trusts
Their strongest outbound trust, strongest first, inferred from their citations.
- G. Dranoff (in Immunology)
Who trusts George C. Prendergast
Papers from George C. Prendergast's perspective
Ordered by how strongly the researchers George C. Prendergast trusts endorse each paper. Same corpus, a different order for every researcher.
- Cytokines in cancer pathogenesis and cancer therapy (Nature Reviews. Cancer)
- Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance. (Advances in Immunology)
- Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase (Nature Medicine)
- BAR Domains as Sensors of Membrane Curvature: The Amphiphysin BAR Structure (Science)
- Ido expression by dendritic cells: tolerance and tryptophan catabolism (Nature reviews. Immunology)
- Cancer Exome Analysis Reveals a T Cell Dependent Mechanism of Cancer Immunoediting (Nature)
- Pembrolizumab for the treatment of non-small-cell lung cancer. (New England Journal of Medicine)
- Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates (Journal of Clinical Oncology)
- Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. (Proceedings of the National Academy of Sciences of the United States of America)
- The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection (Nature Immunology)